Current smoking and response to cholinesterase inhibitor therapy in Alzheimer's disease

被引:6
作者
Connelly, PJ [1 ]
Prentice, NP [1 ]
机构
[1] Univ Dundee, Murray Royal Hosp, Dept Psychiat, Perth PH2 7BH, Scotland
关键词
smoking and Alzheimer disease; cholinesterase inhibitor therapy;
D O I
10.1159/000080964
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Current smoking has been suggested as predicting poor response to cholinesterase inhibitor treatment. This observational study compares response in subjects with NINCDS-ADRDA 'probable' Alzheimer's disease who are current smokers and subjects who are non-smokers. Smoking status was not associated with response. Smokers were significantly more likely to improve Digit Symbol Substitution Test (DSST) scores following treatment. In non-smokers, improvement from baseline DSST scores was associated with good response but this was not the case in smokers. The change in the DSST is in keeping with smokers having increased numbers of nicotinic receptors. In smokers, the lack of association between improvement in DSST scores and good response may be representative of inhibitory properties of cigarette smoke that are unrelated to nicotine. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 23 条
[1]   The effect of apolipoprotein E ε4 in the relationships of smoking and drinking to cognitive function [J].
Carmelli, D ;
Swan, GE ;
Reed, T ;
Schellenberg, GD ;
Christian, JC .
NEUROEPIDEMIOLOGY, 1999, 18 (03) :125-133
[2]   Molecular and cellular aspects of nicotine abuse [J].
Dani, JA ;
Heinemann, S .
NEURON, 1996, 16 (05) :905-908
[3]   Sertraline treatment of elderly patients with depression and cognitive impairment [J].
Devanand, DP ;
Pelton, DH ;
Marston, K ;
Camacho, Y ;
Roose, SP ;
Stern, Y ;
Sackeim, HA .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (02) :123-130
[4]  
FARLOW MR, 1998, NEUROBIOL AGING S4S, V19, P1264
[5]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[6]  
Ke L, 1998, J PHARMACOL EXP THER, V286, P825
[7]   Rates and risk factors for dementia and Alzheimer's disease - Results from EURODEM pooled analyses [J].
Launer, LJ ;
Andersen, K ;
Dewey, ME ;
Letenneur, L ;
Ott, A ;
Amaducci, LA ;
Brayne, C ;
Copeland, JRM ;
Dartigues, JF ;
Kragh-Sorensen, P ;
Lobo, A ;
Martinez-Lage, JM ;
Stijnen, T ;
Hofman, A .
NEUROLOGY, 1999, 52 (01) :78-84
[8]   Development of nicotinic drug therapy for cognitive disorders [J].
Levin, ED ;
Rezvani, AH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :141-146
[9]   α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer' s disease [J].
Martin-Ruiz, CM ;
Court, JA ;
Molnar, E ;
Lee, M ;
Gotti, C ;
Mamalaki, A ;
Tsouloufis, T ;
Tzartos, S ;
Ballard, C ;
Perry, RH ;
Perry, EK .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (04) :1635-1640
[10]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939